David Moadel

David Moadel

Expertise: Stocks, Options, Precious metals, Bitcoin, Altcoins

Education: Master's degree in education from the American College of Education, Bachelor's degree in education from Florida Atlantic University, Associate's degree in liberal arts from Palm Beach Community College

About David:
David Moadel is a financial writer for InvestorPlace.com. He has a master’s degree in education and has authored financial content for multiple websites.

David is also active as a social media influencer, with tens of thousands of followers on YouTube, Twitter, StockTwits, and other popular sites. David writes on topics ranging from stocks to cryptocurrencies, options, precious metals, bonds, futures, and other areas of finance.

Focusing on data rather than emotions, David is always on the lookout for new pathways to financial freedom. Count on David for wealth-building strategies and resources for investors and traders of all financial backgrounds.

You can follow David on YouTube, Twitter, StockTwits and LinkedIn.

Recent Articles

Li-Cycle (LICY) Stock Gains 10% After Receiving Government Loan

News of a potential capital infusion is powering LICY stock higher today, but it could take a while for Li-Cycle to receive the funds.

Count on a Comeback for QuantumScape (QS) Stock

QS stock entered double-digit territory after QuantumScape released its quarterly results, and that's just the start of a much bigger rally.

Why SOFI Stock Is on the Cusp of a Comeback

SOFI stock looks ready to run as a Wall Street expert assesses the potentially positive impact of rising interest rates on SoFi Technologies.

FSR Stock Alert: What to Know About Fisker’s Partnership With ChargePoint

It might be good news that Fisker is teaming up with a charging solutions provider, but FSR stock traders are still in a selling mood today.

Fulcrum Therapeutics (FULC) Stock Plummets 55% on Clinical Hold News

FULC stock is falling fast today due to a regulatory issue, but Fulcrum Therapeutics remains committed to combating sickle cell disease.